Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Lazarus Krikorian net worth and biography

Lazarus Krikorian Biography and Net Worth

CAO of Cencora

Lazarus Krikorian is Senior Vice President and Corporate Controller of AmerisourceBergen. Prior to being named to his current role in 2012, he was Vice President and Assistant Corporate Controller since joining the Company in 2002.

Prior to joining AmerisourceBergen, he held other financial management positions, including Senior Assurance Manager at KPMG LLP, where he spent a decade. He holds a Bachelor of Science in the dual major of Accounting and Finance from Drexel University.

What is Lazarus Krikorian's net worth?: The estimated net worth of Lazarus Krikorian is at least $4.75 million as of December 1st, 2023. Mr. Krikorian owns 19,876 shares of Cencora stock worth more than $4,752,948 as of April 19th. This net worth approximation does not reflect any other investments that Mr. Krikorian may own. Learn More about Lazarus Krikorian's net worth.
How old is Lazarus Krikorian?: Mr. Krikorian is currently 59 years old. There are 7 older executives and no younger executives at Cencora. The oldest executive at Cencora is Ms. Gina K. Clark, Executive VP and Chief Communications & Administration Officer, who is 67 years old. Learn More on Lazarus Krikorian's age.
How do I contact Lazarus Krikorian?: The corporate mailing address for Mr. Krikorian and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Lazarus Krikorian's contact information.
Has Lazarus Krikorian been buying or selling shares of Cencora?: Lazarus Krikorian has not been actively trading shares of Cencora in the last ninety days. Most recently, Lazarus Krikorian sold 2,000 shares of the business's stock in a transaction on Friday, December 1st. The shares were sold at an average price of $203.60, for a transaction totalling $407,200.00. Following the completion of the sale, the chief accounting officer now directly owns 19,876 shares of the company's stock, valued at $4,046,753.60. Learn More on Lazarus Krikorian's trading history.
Who are Cencora's active insiders?: Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.
Are insiders buying or selling shares of Cencora?: During the last year, insiders at the sold shares 21 times. They sold a total of 7,622,034 shares worth more than $1,640,810,686.31. The most recent insider tranaction occured on April, 16th when CEO Steven H Collis sold 10,754 shares worth more than $2,553,859.92. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.
Information on this page was last updated on 4/16/2024.

Lazarus Krikorian Insider Trading History at Cencora

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2023	Sell	2,000	$203.60	$407,200.00	19,876
2/7/2023	Sell	5,711	$155.82	$889,888.02	18,732
12/21/2022	Sell	2,218	$169.24	$375,374.32	20,007
5/11/2022	Sell	4,895	$160.00	$783,200.00	14,079
2/3/2022	Sell	11,653	$138.14	$1,609,745.42
6/8/2020	Sell	19,386	$99.90	$1,936,661.40
11/28/2018	Sell	20,276	$90.37	$1,832,342.12	28,419
11/30/2017	Sell	16,427	$84.86	$1,393,995.22	23,360
3/3/2017	Sell	9,958	$91.83	$914,443.14	15,743
5/8/2015	Sell	21,802	$115.35	$2,514,860.70
2/10/2015	Sell	18,000	$96.03	$1,728,540.00

Lazarus Krikorian Buying and Selling Activity at Cencora

Cencora Company Overview

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Today's Range

Now: $239.13

$236.98

$239.91

50 Day Range

MA: $237.67

$229.96

$245.77

2 Week Range

Now: $239.13

$163.37

$246.75

Volume

1,397,287 shs

Average Volume

1,254,146 shs

Market Capitalization

$47.70 billion

P/E Ratio

26.05

Dividend Yield

0.85%

Beta

0.45

The “Perfect Storm” for Gold

From Gold Safe Exchange | Ad